The Patent Finder

Patrys Limited

Also on record
Records under this name other than patents Patrys Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Patrys Limited

PatentTitleStatus Expires Confidence
US 7,947,812Neoplasm specific antibodies and uses thereof
Lapsed on the fee record
Ended May 24, 2023 · From the USPTO record
Lapsed on the fee recordEnded May 24, 2023From the USPTO record
US 8,741,296Adenocarcinoma specific antibody SAM-6, and uses thereof
Formerly held
Lapsed on the fee record
Ended Jun 3, 2022 · From the USPTO record
Lapsed on the fee recordEnded Jun 3, 2022From the USPTO record
US 8,562,995Neoplasm specific antibodies and uses thereof
Formerly held
Lapsed on the fee record
Ended Oct 22, 2021 · From the USPTO record
Lapsed on the fee recordEnded Oct 22, 2021From the USPTO record
US 9,783,599Lm-Antibodies, Functional Fragments, LM-1 Target Antigen, and Methods for Making and Using Same
Lapsed on the fee record
Ended Oct 10, 2021 · High confidence
Lapsed on the fee recordEnded Oct 10, 2021High confidence
US 8,163,552Adenocarcinoma specific antibody SAM-6, and uses thereof
Formerly held
Lapsed on the fee record
Ended Apr 24, 2020 · From the USPTO record
Lapsed on the fee recordEnded Apr 24, 2020From the USPTO record
US 9,273,125Human monoclonal antibody having fat-reducing effect
Lapsed on the fee record
Ended Mar 1, 2020 · From the USPTO record
Lapsed on the fee recordEnded Mar 1, 2020From the USPTO record
US 8,124,080Human monoclonal antibody having fat-reducing effect
Lapsed on the fee record
Ended Feb 28, 2020 · From the USPTO record
Lapsed on the fee recordEnded Feb 28, 2020From the USPTO record
US 9,265,817Pat-LM1 Epitopes and Methods for Using Same
Lapsed on the fee record
Ended Feb 23, 2020 · High confidence
Lapsed on the fee recordEnded Feb 23, 2020High confidence
US 7,767,787Substance for obtaining highly effective tumor medications as well as a process
Lapsed on the fee record
Ended Aug 3, 2018 · From the USPTO record
Lapsed on the fee recordEnded Aug 3, 2018From the USPTO record
US 7,772,372Neoplasm specific antibodies and uses thereof
Lapsed on the fee record
Ended Aug 10, 2014 · From the USPTO record
Lapsed on the fee recordEnded Aug 10, 2014From the USPTO record
10 of 11 patents shown.
Pro members see all 11.
Pro members: see all 11 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited